Related Experiment Video
Updated: Jan 15, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Predicting Temporal Trends and Hospital-Level Variation in Calcium Modification Strategies Adoption in Percutaneous
Omar M Abdelfattah1, Omar Chaabo2, Joe Aoun2
1Department of Cardiovascular Medicine, Sealy Heart & Vascular Institute, University of Texas Medical Branch, Galveston, Texas, USA.
Background:
The adoption patterns of novel cardiovascular interventional technologies significantly impact patient care and health care resource allocation. This study analyzes and projects the adoption trends of intravascular lithotripsy (IVL) compared to coronary atherectomy (CA).
Objectives:
The objective of the study was to investigate the predicted utilization trends of various calcium modification strategies by year 2035.
Methods:
Leveraging data from multiple U.S.-based registries (2009-2022), we developed Monte Carlo simulations (n = 100,000 simulated iterations) to model adoption trends and hospital-level variations. Logistic growth models were used to project technology adoption rates through 2035.
Results:
IVL showed rapid adoption with a projected terminal rate of 32.41% by year 2035 (95% CI: 28.76% to 36.06%) and mean annual growth of 2.5% (95% CI: 2.1% to 2.9%). CA (rotational and orbital) adoption is projected to reach 4.5 to 5.5% by 2035 (10% to 90% CI: 3.8% to 6.2%). Hospital-level analysis revealed increasing variability in adoption patterns, with high-volume centers (>10% CA use) increasing from 8.6% (2020) to 29.6% (2035).
Conclusions:
This analysis demonstrates divergent adoption patterns between IVL and CA, with IVL showing more rapid uptake. The findings highlight important implications for clinical practice, resource allocation, and health care policy.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Cardiac Catheterization I: Pre-Procedure Overview
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

